Cian Healthcare Limited (BOM:542678)

India · Delayed Price · Currency is INR

26.98

+0.52 (1.97%)

At close: Oct 14, 2026

Market Cap	674.50M +387.1%
Revenue (ttm)	282.99M -8.3%
Net Income	-232.93M
EPS	-9.32
Shares Out	25.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	137
Open	26.98
Previous Close	26.46
Day's Range	26.98 - 26.98
52-Week Range	4.72 - 26.98
Beta	0.56
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 17, 2026

About Cian Healthcare

Cian Healthcare Limited engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India. It offers pharmaceutical products in various therapeutic areas of gynecology, cardio- diabetic, orthopedic, pediatric, dermacosmetic, antibiotic, CNS, and vitamins and nutrient products. The company also provides male and female infertility, reproductive wellness, energy boosting, autism, multivitamins, joint care products, and haematinic products, as well as face and hair serums, veterinary products, and cosmetics... [Read more]

Industry Pharmaceutical Preparations

Founded 2003

Employees 170

Stock Exchange Bombay Stock Exchange

Ticker Symbol 542678

Full Company Profile

Financial Performance

In fiscal year 2026, Cian Healthcare's revenue was 282.99 million, a decrease of -8.28% compared to the previous year's 308.54 million. Losses were -232.93 million, -10.34% less than in 2025.

Financial Statements